药物对比
Troglitazone vs Insulin Icodec
Troglitazone与Insulin Icodec：较老的TZD药物Troglitazone因肝脏风险已撤市；Insulin Icodec通过刺激葡萄糖摄取和抑制葡萄糖生成来调节血糖。
此页面暂无可用的对比维度。
临床背景
Patients with diabetes seeking to compare older thiazolidinediones like Troglitazone with modern basal insulins such as Insulin Icodec.
结论
Insulin Icodec is the preferred modern treatment option, but Troglitazone is no longer available and should not be used.
全部药物对比